ClinVar Miner

Submissions for variant NM_001943.5(DSG2):c.2257del (p.Ala753fs)

dbSNP: rs1567933176
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000706687 SCV000835754 pathogenic Arrhythmogenic right ventricular dysplasia 10 2024-07-21 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Ala753Leufs*15) in the DSG2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 366 amino acid(s) of the DSG2 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DSG2-related conditions. ClinVar contains an entry for this variant (Variation ID: 582579). This variant disrupts a region of the DSG2 protein in which other variant(s) (p.Glu1020Alafs*18) have been determined to be pathogenic (PMID: 20864495, 21397041, 23381804). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Fulgent Genetics, Fulgent Genetics RCV002493249 SCV002791959 likely pathogenic Arrhythmogenic right ventricular dysplasia 10; Dilated cardiomyopathy 1BB 2021-09-18 criteria provided, single submitter clinical testing
Clinical Genomics Laboratory, Washington University in St. Louis RCV000706687 SCV005685155 likely pathogenic Arrhythmogenic right ventricular dysplasia 10 2024-06-08 criteria provided, single submitter clinical testing The DSG2 c.2257del (p.Ala753Leufs*15) variant, to our knowledge, has not been reported in the medical literature. This variant has been reported in the ClinVar database as a pathogenic variant by one submitter and as likely pathogenic by one submitter. This variant is absent from the general population (gnomAD v.2.1.1), indicating it is not a common variant. This variant causes a frameshift by deleting one nucleotide, leading to a premature termination codon, which is predicted to lead to nonsense mediated decay. Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), this variant is classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.